The weekly litigation news digest is live. Subscribe now

Vegf Antagonist Formulations Suitable For Intravitreal Administration - EP2944306

The patent EP2944306 was granted to Regeneron Pharmaceuticals on Jan 27, 2021. The application was originally filed on Jun 14, 2007 under application number EP15169936A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2944306

REGENERON PHARMACEUTICALS
Application Number
EP15169936A
Filing Date
Jun 14, 2007
Status
Granted And Under Opposition
Dec 25, 2020
Publication Date
Jan 27, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOULT WADE TENNANTOct 27, 2021BOULT WADE TENNANTADMISSIBLE
DR H ULRICH DORRIESOct 27, 2021SCHIMMELADMISSIBLE
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBOct 26, 2021WICHMANNADMISSIBLE

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS6436897
DESCRIPTIONUS6676941
DESCRIPTIONUS6777429
DESCRIPTIONUS7033604
EXAMINATIONUS2006217311
OPPOSITIONUS2005043236
OPPOSITIONUS2006058234
OPPOSITIONUS6676941
OPPOSITIONWO0075319
OPPOSITIONWO2005000895
OPPOSITIONWO2005102303
OPPOSITIONWO2006047325
OPPOSITIONWO2006088650
OPPOSITIONWO2006104852
OTHERWO2006104852
OTHERWO2007149334
SEARCHWO2005000895
SEARCHWO2006047325
SEARCHWO2006104852

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents